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Background: To investigate the effects of treatment with Multi component Chinese Medicine Jinzhida (JZD) on
behavioral deficits in diabetes-associated cognitive decline (DACD) rats and verify our hypothesis that JZD
treatment improves cognitive function by suppressing the endoplasmic reticulum stress (ERS) and improving insulin
signaling transduction in the rats’ hippocampus.
Methods: A rat model of type 2 diabetes mellitus (T2DM) was established using high fat diet and streptozotocin
(30 mg/kg, ip). Insulin sensitivity was evaluated by the oral glucose tolerance test and the insulin tolerance test.
After 7 weeks, the T2DM rats were treated with JZD. The step-down test and Morris water maze were used to
evaluate behavior in T2DM rats after 5 weeks of treatment with JZD. Levels of phosphorylated proteins involved in
the ERS and in insulin signaling transduction pathways were assessed by Western blot for T2DM rats’ hippocampus.
Results: Compared to healthy control rats, T2DM rats initially showed insulin resistance and had declines in
acquisition and retrieval processes in the step-down test and in spatial memory in the Morris water maze after
12 weeks. Performance on both the step-down test and Morris water maze tasks improved after JZD treatment. In
T2DM rats, the ERS was activated, and then inhibited the insulin signal transduction pathways through the Jun
NH2-terminal kinases (JNK) mediated. JZD treatment suppressed the ERS, increased insulin signal transduction, and
improved insulin resistance in the rats’ hippocampus.
Conclusions: Treatment with JZD improved cognitive function in the T2DM rat model. The possible mechanism for
DACD was related with ERS inducing the insulin signal transduction dysfunction in T2DM rats’ hippocampus. The
JZD could reduce ERS and improve insulin signal transduction and insulin resistance in T2DM rats’ hippocampus
and as a result improved the cognitive function.
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The prevalence of type 2 diabetes mellitus (T2DM) is in-
creasing rapidly in many industrialized nations, espe-
cially in China [1]. Recently, there has been growing
apprehension about the complications of diabetes, espe-
cially diabetes-associated cognitive decline (DACD).
DACD, also called diabetic encephalopathy (DE) [2], rep-
resents a complication of the diabetic brain and mani-
fests as a gradual decline of cognitive function. Although
the exact mechanisms of DACD have not been fully elu-
cidated, it is known that impaired insulin signaling
transduction involved in the metabolism of Amyloid
Protein (Aβ) and tau [3] plays an important role in
DACD. The activity of Jun NH2-terminal kinase (JNK)
protein is significantly elevated in various tissues in
T2DM patients and animal models, which can impair in-
sulin signaling transduction and lead to insulin resist-
ance through activating the serine phosphorylation of
insulin receptor substrate-1 (IRS-1) [4]. Meanwhile, JNK
is an important downstream signal of the endoplasmic
reticulum stress (ERS) response. Under stressful con-
ditions, three transmembrane endoplasmic reticulum
signaling proteins then dissociate from molecular
chaperone 78-kD glucose-regulated protein (GRP78/Bip)
and activate JNK [5]. Recently, several reports about
Alzheimer’s Disease (AD) support a mechanistic connec-
tion between ERS and AD [6-8], which had similar path-
ology changes, but whether ERS plays a role in DACD is
not clear. We hypothesized that ERS-induced JNK acti-
vation impairs insulin signaling transduction, resulting
in DACD in the hippocampus of T2DM rats.
Currently, there are no effective treatments that can
prevent the development of DACD in T2DM. Trad-
itional Chinese Medicines (TCMs) have been used for
centuries in China in the prevention and treatment of
many diseases and have proven to be effective and safe
for clinical use. As a result, they have attracted global
attention [9,10]. May and his colleagues [11] published
a systematic review of the effectiveness and safety of
TCMs for treating early dementia. They concluded that
Chinese herbs could improve cognitive and memory im-
pairment and could be useful in the treatment and pre-
vention of early dementia, including AD.
Multi-component Chinese medicine theory is a new
Traditional Chinese Medicines theory system, which was
first proposed by the Tianjin University of Traditional
Chinese Medicine Zhang Boli professor [12]. It followed
the principle of Chinese medicine prescription compati-
bility principle, application of effective components or
effective parts extracts compatibility formula. The Multi
component Chinese Medicine Jinzhida (JZD) from green
tea, ginseng and polygala are complex extracts made of
theanine, tea polyphenols, ginsenosides and polygalic
acid and were designed according to the theory ofMulti-component Chinese medicine. Each of these sub-
stances therefore has been shown to have neuroprotective
functions, and each has a clear mechanism of action
[12-14]. These compounds are compatible when taken to-
gether, and it is thought that their concurrent use may
amplify the therapeutic efficacies of each component. This
results in maximal therapeutic efficacy with minimal ad-
verse effects, similar to the results of “cocktail therapies”
for AIDS [15]. We therefore sought to evaluate the effects
of these compounds in combination on DACD by treating
streptozotocin-induced DACD rats with JZD.
Methods
Preparation of multi component Chinese medicine
Jinzhida
Multi component Chinese Medicine Jinzhida (JZD) are
complex extracts derived from tea polyphenols, theanine,
ginsenosides and polygalic acid, which were mixed in a
blender in a ratio of 3:3:2:1 by weight. Tea polyphenols
were purchased from Wufeng Tianjian Plant Products
Ltd. (Hubei Province, China), theanine from Jintan City
Qianyao Pharm Co. Ltd. (Jiangsu Province, China),
ginsenosides from Fusong County Natural Biotechnology
Ltd. (Jilin Province, China) and polygalic acid from Jingyue
Plant and chemical technology Ltd. (Sanxi Province,
China) They were dissolved in double-distilled water and
concentrated to 39 mg/kg, 104 mg/kg and 390 mg/kg for
the low, middle and high dose groups, respectively.
Animals
All animal experiments were conducted in accordance
with the NIH Principles of Laboratory Animal Care and
the institutional guidelines for the care and use of labora-
tory animals at Dalian Medical University(Dalian, China).
Eight weeks-old male Sprague–Dawley (SD) rats weighing
200 ± 20 g were obtained from the Experimental Animal
Center at Dalian Medical University, Dalian City, Liaoning
Province, China, license number: SCXK (Liaoning Prov-
ince) 2008–0002. Rats were allowed to acclimatize in an
environmentally-controlled room (with a temperature
of 22 ± 3°C and humidity of 55 ± 5%) with an alternating
12 h light/dark cycle and free access to chow and water.
After 3 days acclimation, rats in the T2DM group were
fed a high-fat diet (40% fat, 25% protein and 35% carbo-
hydrate, as a percentage of total kcal; Anlimo Technol-
ogy, Nanjing, China) [16] and in the control group were
fed a standard diet. After 4 weeks of a high-fat diet, rats
were fasted for 12 h (with free access to water), and each
rat was injected intraperitoneally with 30 mg/kg
streptozotocin (STZ; Sigma, St. Louis, MO, USA) in
0.1 M citrate buffer solution, pH 4.4. Rats in the control
group were injected with the citrate buffer solution [17].
Random blood sugar (RBS) levels were measured in
blood obtained by clipping the tails of the rats. A
Chang et al. BMC Complementary and Alternative Medicine 2013, 13:161 Page 3 of 11
http://www.biomedcentral.com/1472-6882/13/161measurement of ≥16.7 mmol/L 3 days after STZ injec-
tion was considered diagnostic of T2DM [18].
After streptozotocin injection, fasting serum insulin
(FSI) levels were obtained, and glucose tolerance tests
(OGTT) and insulin tolerance tests (ITT) were per-
formed. Samples for FSI were taken from the angular
vein and analyzed using a radioimmunoassay kit (Atom
High-tech, Beijing, China). Glucose (50% [wt/wt]; 2 g/kg,
given orally) and regular human insulin (0.75 U/kg;
Novo Nordisk, Tianjin, China) were used in the OGTT
[19] and ITT [20], respectively.
Experimental groups and treatments
A total of 28 rats that developed T2DM and had com-
parable body weights were chosen and randomly divided
into three treatment groups and a DACD model group
as described in Table 1. Rats in the three treatment
groups received different concentrations of JZD 1 ml/
100 g orally twice a day for 5 weeks. The DACD model
(Mod) and control (Cont) group rats received isotonic
Na chloride as control injections.
Behavioral experiments
Behavioral tests, including Step-down tests and Morris
water maze tests, were conducted during the last 7 days
of treatment according to the following schedule: Day
1–2 step-down test and Day 3–7 Morris water maze test.
The rats were subsequently euthanized.
Step-down test
The training apparatus was a 60 cm × 20 cm × 20 cm
plastic box, the floor of which was made of parallel
0.1 cm-caliber stainless steel bars spaced 0.5 cm apart.
An elevated rubber platform (diameter: 10 cm, height:
4.5 cm) was placed by the left wall of the training box
apparatus. On the first training day, rats were first ex-
posed to a 5-min learning course, during which they
were permitted to move freely through the chamber, and
were then placed on the platform. If the animals stepped
down from the platform (“error trial”), they were
punished by an electric foot shock (36 V, AC). The num-
bers of “errors” (steps down from the platform) during
the training period were recorded. After 15 minutes of
training, the rats were placed on the platform and theTable 1 Experimental groups and treatments
Group N Type of animals Treatment
Cont 10 Normal rats Isotonic Na chloride
Mod 7 T2DM rats Isotonic Na chloride
LJZD 7 T2DM rats Low-dose JZD
MJZD 7 T2DM rats Middle-dose JZD
HJZD 7 T2DM rats High-dose JZDlatency to step-down was recorded as the 1st learning
grade (D1 latency). After 24 h, the latency was assessed
again and recorded as the 2nd learning grade (D2
latency), which was taken as a measure of memory
retention.
Morris water maze
The apparatus consisted of a circular pool (50 cm
height × 120 cm diameter) filled with 26 ± 1°C water
made opaque with milk. A clear Plexiglas platform
(29 cm high × 9 cm diameter) was submerged 1 cm
below the water surface. The pool was divided into four
equal quadrants and each quadrant was marked by a dif-
ferent visual cue. The platform was randomly placed in
one quadrant for the duration of the experimental pro-
cedure. On the first day, rats were given a 120 s habitu-
ation session in the pool without the platform. On the
following 4 days, each rat received four 120 s learning
trials with the platform, with 60 s resting periods be-
tween trials. For each learning trial, rats were placed into
the water facing the pool wall at one of four points of
entry. The escape latency (time needed to locate the sub-
merged platform) was recorded for each trial. If a rat
was unable to locate the platform within 120 s, it was
led to the platform and allowed to rest there for 60 s.
The escape latency in these cases was recorded as 120 s.
After completion of the learning trials, the platform was
removed from the pool. Each rat was then subjected to a
120 s memory retention test, in which the amount of
time and frequency the rat spent swimming in the same
quadrant as the platform had previously been hidden
was recorded [18].
Sample preparation
After behavioral tests, the animals were anesthetized
with intraperitoneal injection of 4% chloral hydrate and
euthanized. Brain structures were removed and stored
at −80°C until further use. The hippocampus was then
isolated for protein preparation. Briefly, based on histo-
logical observations, the border of the selected region
was identified in the cross section of the frozen speci-
men and was marked gently with an autoclaved surgical
knife. According depending on the size of the region of
interest, eight to sixteen sections (10 μm per section)
were used for protein preparation. Tissues were col-
lected with an autoclaved pipette tip and placed immedi-
ately into 25 μl of pre-chilled 2× Laemmli SDS sample
buffer (0.125 M Tris–HCl pH 6.8, 4% SDS, 20% v/v gly-
cerol and 0.2 M DTT) [21]. Samples were subjected to
ultrasound for 10 min in pre-chilled water, then boiled
and denatured for 5 min. The sample was then
maintained at 4°C and centrifuged at 15,000 rpm for
5 min, after which the supernatant was collected. Protein
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assay reagent (Pierce Biotechnology, Rockford, IL, USA)
and absorbance measured at 595 nm with a Bradford
protein assay and using bovine serum albumin as the
protein standard.Western blot analysis
All chemicals for western blot analysis purchased from
Sigma-Aldrich.Shanghai Ltd. (Shanghai, China). For each
sample, 50 μg of protein was loaded in each lane were
separated in a 8-12% SDS-polyacrylamide gel and trans-
ferred to a nitrocellulose membrane (Bio-Rad, CA). The
membrane was blocked with 5% skim milk in PBS for
3 h and washed in Tris-buffered saline three times. The
membrane was then incubated overnight at 4°C with
one of the following primary antibodies: anti- phosphor-
ylated protein kinase RNA-like endoplasmic reticulum
kinase (anti-PERK) 1:1,000, anti-Jun NH2-terminal kin-
ase (anti-JNK) 1:1,000 (Santa Cruz, USA), anti- inositol-
requiring enzyme-1(anti-IRE1) 1:1,000, anti-α subunit
of translation initiation factor 2 (anti-eIF2α) 1:500,
antiphospho-eIF2α 1:500, antiphospho-JNK 1:1,000,
antiphospho-PERK 1:800 , anti-protein kinase B (anti-
AKT) 1:1,000 or antiphospho-AKT 1:800 (Cell Signaling,
USA), antiphospho-IRE1 1:800 (Abcam, UK), anti-78-kD
glucose-regulated protein (anti-GRP78) 1:800 (Stressgen,
CA), anti-insulin receptor substrate-1 (anti-IRS-1) 1:1,000 ,
antiphospho-IRS-1 (ser307) 1:1,000 (Upstate, USA) and
monoclonal anti-β actin (Sigma, USA). After incubation
with primary antibody, the membrane was then incubated
for 3 h at room temperature with an anti-rabbit or an
anti-mouse IgG HRP-linked antibody (GE Healthcare,
UK) at a dilution of 1:2,500. Immunoreactive bands were
detected using the Lumi-Light Western Blotting Substrate
(Roche, USA). The intensity of bands was measured with
an imaging system (UVP, USA) coupled with LabWorks
4.6 analysis software. The relative intensities were calcu-
lated by dividing by anti-β actin. The bands were analyzed
according to the relative density of each antibody, which is
obtained by dividing the density of each antibody value by
the internal reference β-Actin.Table 2 Effect of high-fat diet and STZ injection on general ch
Parameters Cont group
Before injection After
Body weight (g) 344.09 ± 16.56 350.20
Food intake (g) 29.02 ± 2.65 29.90
Water intake (ml) 48.60 ± 3.50 43.90
Rectal temperature (°C) 37.01 ± 0.41 37.11
RBS (mmol/L) 4.96 ± 0.27 5.50 ±
FSI (mIU/L) 13.70 ± 2.10 13.17
Data are given as mean ± SD., * p < 0.05, **p < 0.01 vs. the Cont group. RBS randomStatistical analysis
Data were expressed as means ± SD. Statistical signifi-
cance was analyzed using ANOVA, followed by least-
significant difference post hoc with SPSS 13.0 (SPSS,
Chicago, IL, USA). A p value of <0.05 was considered to
be statistically significant.
Results
Assessment of T2DM rat model
Healthy male Sprague–Dawley (SD) rats were fed with a
high-fat diet. After 4 weeks, the high-fat diet resulted in
a significant increase in body weight and hyperinsu-
linemic (p < 0.05), which suggests that rats have already
developed obesity and insulin resistance. Injection of
STZ significantly increased RBS levels in T2DM rats
(p < 0.05), thus producing hyperglycemia (Table 2). FSI
levels and the body weight were reduced slightly after
STZ injection but remained higher than that of controls
(p < 0.05) (Table 2). Meanwhile, the rats in T2DM group
appeared polydipsia and polyphagia.
T2DM rats exhibited severe hyperglycemia upon ad-
ministration of glucose and exhibited impaired glucose
tolerance following OGTT (Figure 1A). Insulin sensitiv-
ity detected by ITT was also impaired in the T2DM rats.
(Figure 1B and 1C).
Improvement of behavioral by JZD
After JZD treatment, behavioral tests were performed.
Day 1 of the step-down test was the memory acquisition
period. The latency to step-down and numbers of errors
were significantly increased in the Mod group compared
to the Cont group (p < 0.05) (Figure 2A). JZD treatment
improved memory acquisition; there was a significant
improvement in both latency time and number of errors
in the HJZD group compared to the Mod group
(p < 0.05). There was no significant difference in perform-
ance between the Cont group and the HJZD group
(p > 0.05). Even though in the LJZD and MJZD groups, la-
tency was slightly decreased compared to the Mod group,
but the difference was not statistically significant. Memory
consolidation was evaluated on D2. The latency to step-
down was significantly longer and the number of errorsaracteristics of type 2 diabetic rats
T2DM group
injection Before injection After injection
± 21.07 383.10 ± 17.80 * 377.54 ± 17.66 *
± 2.16 29.13 ± 3.25 34.39 ± 1.85 *
± 1.35 46.10 ± 5.27 61.72 ± 4.82 *
± 0.38 37.15 ± 0.59 37.48 ± 0.33
1.04 5.13 ± 0.26 21.35 ± 4.20 **
± 4.65 33.27 ± 7.18 * 20.55 ± 8.15 *
blood sugar, FSI fasting serum insulin.
Figure 1 Assessment of the type 2 diabetic rat model. (A) Fasting blood-glucose levels following glucose challenge (50%, 2 g/kg) performed
after STZ injections. (B) Fasting blood-glucose levels following insulin challenge (0.75 IU/kg) performed after STZ injections. (C) Fasting blood-glucose,
represented as the percentage change from baseline, is reduced following insulin challenge (0.75 IU/kg) performed after STZ injection. Data are
represented as means ± SD, * p < 0.05, **p < 0.01 vs. the Cont group. FBG, fasting blood-glucose.
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group compared with the Mod group (p < 0.05). Interes-
tingly, all rats in the HJZD group exhibited latencies of
300 s and all had zero errors during the memory consoli-
dation test (Figure 2B).
In the Morris water maze, Day 1 was a habituation ses-
sion and escape latency from D2 to D5 were statisticallyFigure 2 Effect of JZD on step-down test of DACD rats. (A) Latencies a
Mod group were longer than those of the Cont and HJZD groups. Numbe
step-down test. The Mod group had more errors than Cont and HJZD grou
test. Latencies of the Mod group were shorter than those of the Cont and
period on Day 2 of the step-down test. The Mod group had more errors th
down from the platform on the second day. Data are represented as mean
vs. the Mod group.analyzed. Figure 3 shows that escape latency to locate the
hidden platform was significantly shorter in the Cont and
HJZD groups compared to the Mod, LJZD and MJZD
groups (p < 0.05). Performance of the Cont and HJZD
groups was not statistically different (p > 0.05). Escape la-
tency from D2 through D5 were similar for the Mod,
LJZD and MJZD groups and were significantly higher thannd numbers of errors on Day 1 of the step-down test. Latencies of the
rs of errors during the memory acquisition period on Day 1 of the
ps. (B) Latencies and numbers of errors on Day 2 of the step-down
HJZD groups. Numbers of errors during the memory consolidation
an Cont and HJZD groups. None of the HJZD group rats stepped
s ± SD, * p < 0.05, ** p < 0.01 vs. the Cont group, # p < 0.05, # # p < 0.01
Fig 3 Effect of JZD on escape latency during the Morris water
maze test in DACD rats. Graphs show mean time ± SD taken to
reach the platform (escape latency) for Days 2 through 5. A
significant decrease in the escape latency to reach the platform was
found on Days 2 through 4 and remained stable on Day 5. Factorial
ANOVA showed that the Cont and HJZD groups had a significantly
lower retent time on days 2–5 than the other groups. Data are
represented as means ± SD, * p < 0.05 vs. the Cont group, # p < 0.05 vs.
the Mod group.
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obtained the similar results in the retention test ,which
could suggest spatial memory capacity of rats (Table 3).Effect of JZD on indicators of hippocampal ERS
Protein expression levels were determined for several
ERS markers, such as PERK, IRE-1α and eIF2α, in hip-
pocampal tissues from rats. The levels of phosphorylated
ERS proteins were significantly higher in Mod rats than
in the Cont and JZD-treated groups. During the JZD
treatment, the expression of phosphorylated ERS indica-
tors was decreased compared to the Mod group, especially
in the HJZD group the expression of phosphorylated
ERS indicators was decreased significantly (p < 0.05)
(Figure 4A).
Under normal conditions, the ER chaperone protein
GRP78 binds the transmembrane proteins PERK, IRE-
1Α, and ATF6 to form an inactive complex [22]. Under
conditions of stress, these ERS indicators dissociate from
GRP78 and are autophosphorylated and subsequently
activated [23]. We detected higher GRP78 levels in hip-
pocampal tissues of the Mod group than those of the
Cont group. Treatment with JZD the GRP78 expression
level was decreased especially in the HJZD group (p < 0.05)
(Figure 4B).Table 3 Effect of JZD on Morris water test objective quadrant
Group Cont group Mod group
Time(s) 12.75 ± 2.05 5.01 ± 1.66 **
Frequencies 10.00 ± 1.24 5.42 ± 0.90 **
Data are represented as means ± SD, * p < 0.05, ** p < 0.01 vs. the Cont group, # p <Effect of JZD treatment on markers of insulin resistance
and insulin signaling transduction
JNK is an important marker of ERS downstream signal-
ing pathways. Insulin resistance is associated with the
activation of JNK and subsequent JNK-mediated serine
phosphorylation of IRS-1 at Ser-307 that negatively
regulates the insulin signaling pathway[24]. AKT is a
marker of insulin signaling transduction sensitivity. We
found that the levels of p-JNK and p-IRS-1 (ser307)
were elevated and p-AKT was decreased in the hippo-
campus of the Mod group rats compared to the Cont
group rats. Treatment with JZD suppressed phosphoryl-
ation of JNK and IRS-1(ser307) but increased AKT
phosphorylation (Figure 5).
Discussion
There is a close relationship between T2DM and
Alzheimer’s disease (AD). This relationship is perhaps
due in part to the effects of sustained hyperglycemia on
the central nervous system (CNS), though hypercholes-
terolemia and hypertension caused by metabolic syn-
drome can also affect the CNS. These effects result in
mild to moderate cognitive dysfunction, decline in learn-
ing and memory, or even AD [25]. Recent studies have
shown the cognitive decline in the hippocampus of pa-
tients with T2DM [26,27]. Furthermore, AD-like patho-
logical changes such as abnormal Aβ deposition and tau
hyperphosphorylation were discovered in patients with
T2DM [28] and diabetic animal models [29].
Tea as a traditional medicine was used in the Chinese
medicine prescription has undergone a very long history
period. In ancient China, some famous tea therapy
recipes were widely used, which could improve the
intelligence and cognitive function. Modern pharmacol-
ogy research also shows that the main ingredients, poly-
phenols and theanine, have the function both slowing
the aging and improving cognition and neuroprotective
functions [30,31]. So polyphenols and theanine were
used as the principal drug in the prescription of JZD.
Ginsenosides have the effects of benefiting qi, restoring
pulse and treating collapse, tonifying the spleen and
lung, promoting the production of body fluid to quench
thirst, tranquilizing the mind and improving cognition.
Ginsenosides have also been demonstrated to have
neuroprotective effects in vitro [32] and in vivo [33] and
have been shown to improve behavioral deficits. Polygala
has the effects of relieving mental distress, tranquilizing
the mind, removing phlegm to induce resuscitation,retention time and frequencies of DACD rats
LJZD group MJZD group HJZD group
7.34 ± 1.02 * 10.92 ± 1.81# 10.43 ± 1.46 ##
6.18 ± 1.13 * 7.57 ± 1.74 # 8.43 ± 1. 06 ##
0.05, ## p < 0.01 vs. Mod group.
CA
B
Figure 4 Effect of JZD on indicators of DACD rat hippocampal ERS. (A) Representative protein levels of PERK , IRE-1α and eIF2α and their
phosphorylated forms from hippocampal tissues of the Cont, Mod and JZD-treated rats were assessed by Western blotting using specific
antibodies. (B) GRP78 in hippocampal tissues of the Cont, Mod and JZD-treated rats were assessed by Western blotting. (C) The relative densities (R.D.) of
each protein are represented. The relative densities are obtained by dividing the density of each antibody value by the internal reference β-Actin. Data are
represented as means ± SD, n = 5 per group. * p< 0.05, ** p< 0.01 vs. the Cont group, # p< 0.05, # # p< 0.01 vs. the Mod group.
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mal experiments[14,34], polygalic acid could significantly
ameliorate memory impairment, particularly in short-
term memory, which is most affected in the early stages
of AD. So ginsenosides and polygalic acid were used as
the assistant drug in the prescription of JZD. In accord-
ance with theories of TCMs, JZD has the therapeutic ef-
fects of including replenishing qi, tranquilizing the mind
and improving the cognitive function. Moreover, JZD
has already been utilized in the clinical setting to treat
patients with AD or mild cognitive impairments withgood results. In scopolamine-induced AD mouse
models, we had previously demonstrated improvements
in cognitive function with JZD (data not shown). Given
the close associations between AD and DACD, we hoped
to verify the therapeutic effects of JZD on DACD in
T2DM rats.
We induced T2DM in rats with a high-fat diet and
low-dose STZ injections [16]. First, rats fed a high-fat
diet develop insulin resistance and obesity, then low-
dose STZ induced a mild impairment of insulin secre-
tion that was similar to a feature of T2DM. This model
A B
Figure 5 Effect of JZD on markers of insulin resistance and insulin signal transduction in the hippocampus of diabetic rats.
(A) Representative protein levels of JNK, IRS-1, AKT and their phosphorylated forms from hippocampal tissues of the Cont, Mod and JZD-treated
rats were assessed by Western blotting using specific antibodies. (B) The relative densities (R.D.) of each protein are represented. The relative
densities are obtained by dividing the density of each antibody value by the internal reference β-Actin. Data are represented as means ± SD,
n = 5 per group. * p < 0.05 vs. the Cont group, # p < 0.05 vs. the Mod group. group.
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characteristics of T2DM in human [34]. Cognitive deficits
gradually begin within eight weeks of diabetes induction
and reached a maximum after 12 weeks [35]. We tested
cognitive performance after setting up T2DM model
12 weeks with the step-down test and the Morris water
maze (MWM). These two tests are common utilized for
evaluating learning and memory in rats and mice [36].
The step-down test is a classic model behavioral test. In
our study, we observed a significant increase in step-
down latency and numbers of errors on D1 of the step-
down test in DACD rats, suggesting memory acquisition
capacity impairment in these animals. The step-down la-
tency was significantly shorter and the numbers of errors
were significantly more on D2 of the step-down test in
DACD rats, suggesting memory consolidation capacity
impairment in these animals. These results are in agree-
ment with other studies that have also verified cognitive
impairment in streptozotocin-induced diabetes mellitus
[37,38]. However, when the DACD rats were treatedwith JZD, the step-down latency in the step-down test
was similar to that found for rats from the control
group. These findings indicate that treatment with JZD
was able to prevent learning and memory impairment
induced by diabetes. The MWM is a test of spatial learn-
ing and reference memory. The DACD rats showed en-
hanced spatial learning and memory in the MWM
behavioural testing. The JZD-treated rats had a lower la-
tency to reach the hidden platform from day 2 onwards;
the decrease reached a significant level on day 5. This
was in accordance with previous studies [18,35,39,40].
One important link between AD and T2DM is insulin
resistance in the CNS due to alterations in insulin recep-
tor sensitivity and insulin signaling transduction. These
alterations affect the expression and metabolism of Aβ
[41] and tau proteins [42] and also affect synaptic plasti-
city [43] and neural cell degeneration processes [44] in-
volved in cognitive function [45]. For this reason, we
used the T2DM rat model to investigate the mechanisms
of DACD as well as CNS insulin resistance and insulin
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insulin signaling transduction in the hippocampus was
observed in DACD rats, and the impairment could be
improved by JZD. We analyzed the impairment of in-
sulin signaling in the hippocampus in T2DM rats in
several different ways. The inhibition of brain insulin
phosphatidylinositol 3 kinase/protein kinase B (PI3K/
AKT) signaling pathways accelerated Aβ fibrillogenesis
by inducing GM1 ganglioside clustering in the presynap-
tic membranes of primary neurons [46]. Moreover, the
insulin-activated AKT phosphorylation antagonized Aβ-
induced neural cell apoptosis by restoring the mitochon-
drial membrane potential [47]. The insulin-resistant
state induced by STZ intracerebroventricularly (icv) in-
jection in Tg2576 mice exacerbated AD-like changes,
such as spatial cognitive impairment, and increased Aβ
and total tau protein levels [48]. Meanwhile, the phos-
phorylation of the insulin receptor and AKT reduction
could increase glycogen synthase kinase-3β (GSK3β) ac-
tivity. This insulin signaling impairment was associated
with a concomitant increase in tau phosphorylation
levels [49]. The insulin signal impairment also affects
synaptic plasticity and neural cell degeneration involved
in cognitive function. Soeda [50] found that inhibition of
inositol polyphosphate-5 phosphatase-like 2(SHIP2), a
potent negative regulator of insulin/ insulin-like growth
factor-I(IGF1) actions in the brain, ameliorated the im-
pairment of hippocampal synaptic plasticity and memory
formation in db/db mice. Li [51] reported activating
AKT/ERK could induce the neuronal apoptosis in dia-
betic mice.
As insulin signaling transduction affected cognitive
function, we therefore investigated the mechanisms of
DACD as well as CNS insulin resistance and insulin sig-
naling transduction in T2DM rats. We found increased
levels of the phosphorylated form of the insulin resist-
ance marker IRS-1 ser 307 and decreased levels of the
downstream target AKT in T2DM rat hippocampus.
Treatment with JZD decreased the IRS-1 phosphoryl-
ation levels at ser307 and result in the AKT phosphoryl-
ation levels increasing. These results demonstrate that
JZD may improve cognitive impairment by reducing the
brain’s insulin resistance and promoting recovery of in-
sulin signal transduction.
Under diabetic conditions, the ERS response is in-
duced in various tissues [52], leading to activation of the
JNK pathway. In tissues such as liver, adipose tissue,
muscle or cardiac myocytes that have become insulin-
resistant, ERS promotes JNK-dependent serine phosphor-
ylation of IRS-1, which in turn inhibits insulin signal
transduction. Su et al. [53] suggested that hepatic ERS
induced by apolipoprotein B100 led to abnormal ac-
tivation of glycogen synthase, by way of activation of JNK
and suppression of the insulin signaling cascade. Incardiomyocytes from ethanol-fed mice. Li and Ren [54]
found that serine phosphorylation of IRS-1 decreased
phosphorylation of AKT. GSK-3β expression was reduced,
JNK was activated and the ERS markers eIF2α, IRE-1α,
GRP78 and Gadd153 were upregulated. They concluded
that elevated cardiac acetaldehyde exposure may exacer-
bate alcohol-induced myocardial dysfunction, hyper-
trophy, insulin insensitivity and ERS. Sreejayan [55] also
showed that markers of insulin resistance (phospho-c-Jun
and IRS-1 phosphoserine) and ERS (p-PERK, p-IRE-1Α,
p-eIF2α) were elevated in liver and cultured muscle cells
in ob/ob mice. These studies demonstrate that ERS is re-
duced by various factors and could inhibit the insulin sig-
naling pathway and lead to insulin resistance by activation
of phosphorylation of JNK in peripheral organs. Moreover,
there is an insulin signaling cascade in the rat hippocam-
pus similar to that described in peripheral tissues[56]. In-
sulin resistance is present in the brain and decrease
glucose metabolism [56]. As a result, neuronal activity in
the hippocampus rapidly decreases with hippocampal-
dependent learning and memory [57]. So we hypothesized
that, under diabetic conditions, ERS is reduced, the insulin
signaling pathway is inhibited, and insulin resistance is
worsened by activation of JNK in the CNS. We assessed
the expression of insulin signal transduction and ERS by
Western blotting in the hippocampus in the T2DM rat
model to verify our hypothesis. In our study, T2DM rats
showed activation of ERS, as demonstrated by the in-
creased expression of phosphorylated ERS hallmarks.
They also demonstrated impairment of insulin signal
transduction, resulting in increased activation of JNK, in-
creased serine phosphorylation of IRS-1, and decreased
function of AKT. Treatment with JZD significantly im-
proved cognitive function of T2DM rats. On a molecular
level, JZD treatment reduced ERS and improved insulin
signal transduction in the hippocampus. These experi-
mental results confirmed our hypothesis. One of the im-
portant principles underlying TCMs is that several
extracts in combination may play coordinate roles to en-
hance the treatment effects in complex diseases. However,
at present, we do not know which extract is most efficient.
We plan to carry out further studies to identify the most
effective composition of JZD.
Conclusions
The results of this study demonstrate that JZD treatment
with improved cognitive function in the T2DM-DACD
rat model. The possible mechanism for DACD was re-
lated with ERS inducing the insulin signal transduction
dysfunction in T2DM rats’ hippocampus. The JZD could
reduce ERS and improve insulin signal transduction and
insulin resistance in T2DM rats’ hippocampus and as a
result improved the cognitive function.
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